P62508 (ERR3_HUMAN) Homo sapiens (Human)

Estrogen-related receptor gamma UniProtKBInterProSTRINGInteractive Modelling

458 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5); 65 identical sequences

Available Structures

40 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WI… Heteromer
Q15788;
233-458
Assess
Estrogen Related Receptor-gamma ligand binding domain complexed with a RIP140 peptide and synthetic… Heteromer
P48552;
233-457
1BA;
Assess
Estrogen Related Receptor-gamma ligand binding domain complexed with a synthetic peptide from RIP140 Heteromer
P48552;
235-458
Assess
Estrogen Related Receptor-gamma ligand binding domain complexed with 4-hydroxy-tamoxifen and a SMRT… Heteromer
Q4RA23;
232-455
OHT;
Assess
X-ray structure of the orphan nuclear receptor ERR3 ligand-binding domain in the constitutively act… Heteromer
Q15788;
235-456
Assess
Ternary complex of 14-3-3 sigma (C38N), Estrogen Related Receptor gamma (DBD) phosphopeptide, and d… Heteromer
P31947;
175-182
MG;CL;O85;
Assess
Binary complex of 14-3-3 sigma (C38N) with the Estrogen Related Receptor gamma (DBD) phosphopeptide Heteromer
P31947;
175-182
MG;CL;
Assess
Ternary structure of 14-3-3s, ERRg phosphopeptide and dual-reactive compound 7 Heteromer
P31947;
175-182
MG;CL;QQ0;
Assess
Ternary structure of 14-3-3s, ERRg phosphopeptide and dual-reactive compound 6 Heteromer
P31947;
175-182
MG;CL;QL9;
Assess
Ternary structure of 14-3-3s, ERRg phosphopeptide and dual-reactive compound 8 Heteromer
P31947;
175-182
MG;CL;QL0;
Assess
Ternary complex of 14-3-3 sigma (C38N), Estrogen Related Receptor gamma (DBD) phosphopeptide, and d… Heteromer
P31947;
175-181
MG;CL;O68;
Assess
Ternary complex of 14-3-3 sigma (C38N), Estrogen Related Receptor gamma (DBD) phosphopeptide, and d… Heteromer
P31947;
175-181
MG;CL;O3W;
Assess
Ternary complex of 14-3-3 sigma (C38N), Estrogen Related Receptor gamma (DBD) phosphopeptide, and d… Heteromer
P31947;
175-181
MG;CL;O4E;
Assess
Ternary structure of 14-3-3s, ERRg phosphopeptide and dual-reactive compound 5 Heteromer
P31947;
175-181
MG;CL;OYI;
Assess
Binary complex of 14-3-3 sigma (C38N) with the Estrogen Related Receptor gamma (LBD) phosphopeptide Heteromer
P31947;
316-321
MG;
Assess
Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with bisph…homo-2-mer232-458
2OH;GOL;
Assess
Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with bisph…homo-2-mer232-458
BPZ;GOL;
Assess
Crystal structure of human estrogen-related receptor gamma ligand binding domain apo formhomo-2-mer232-458
Assess
Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with BPA-m…homo-2-mer232-458
CW6;
Assess
Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with 4-alp…homo-2-mer232-458
1OH;GOL;
Assess
Crystal structure of human ERRg LBD in complex with tetrahydro-2-naphtolhomo-2-mer234-458
H42;GOL;
Assess
crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex wi…homo-2-mer232-456
OHT;CHD;
Assess
Crystal structure of human ERRg LBD in complex with bisphenol-Ahomo-2-mer234-458
2OH;
Assess
Estrogen Related Receptor-gamma ligand binding domainhomo-2-mer234-458
CA;
Assess
Crystal structure of human ERRg LBD in complex with 4-iso-propylphenolhomo-2-mer234-457
H3Z;
Assess
Crystal structure of human ERRg LBD in complex with bisphenol-Bhomo-2-mer234-457
H3W;EDO; 10×GOL;
Assess
Crystal structure of human ERRg LBD in complex with HPTEhomo-2-mer234-457
27N;
Assess
Crystal structure of human ERRg LBD in complex with bisphenol-Ehomo-2-mer234-457
H48;GOL;
Assess
Crystal structure of Estrogen Related Receptor-3 (ERR-gamma) ligand binding domaind with tamoxifen …homo-2-mer233-456
TXF;
Assess
Crystal structure of human ERRg LBD in complex with 4-sec-butylphenolhomo-2-mer234-456
H4Q;GOL;
Assess
Estrogen Related Receptor-gamma ligand binding domain complexed with 4-hydroxy-tamoxifenhomo-2-mer234-455
OHT;
Assess
crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex wi…homo-2-mer233-450
DES;
Assess
crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex wi…homo-2-mer233-442
OHT;
Assess
Crystal structure of estrogen related receptor-gamma DNA binding domain complexed with Pla2g12b pro…homo-2-mer124-203
ZN;MLI;
Assess
Crystal Structure of Estrogen Related Receptor g in complex with 3-methyl phenolmonomer234-456
43M;
Assess
X-ray Structure of Estrogen Related Receptor g in complex with Bisphenol A.monomer235-456
NA;2OH;
Assess
Crystal structure of Estrogen Related Receptor-3 (ERR-gamma) ligand binding domain with DN200434monomer234-455
90C;
Assess
Crystal structure of Estrogen-related receptor gamma ligand-binding domain with DN200699monomer235-456
DL9;
Assess
Crystal structure of Estrogen-related Receptor-3 (ERR-gamma) ligand binding domain with DN201000monomer235-455
9S6;
Assess
Estrogen Related Receptor Gamma in complex with 4-hydroxy-tamoxifenmonomer235-441
OHT;
Assess

13 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7prw.1.Amonomer0.65125-456
ZN;30.72
Assess
7prw.1.Bmonomer0.65125-456
ZN;30.72
Assess
5uan.1.Amonomer0.65126-456
ZN;36.59
Assess
4nqa.1.Amonomer0.64121-455
ZN;36.59
Assess
7wnh.4.Amonomer0.63128-456
ZN;31.52
Assess
4nqa.1.Bmonomer0.63124-455
ZN;27.11
Assess
3dzy.1.Amonomer0.63125-454
ZN;36.59
Assess
5uan.1.Bmonomer0.62127-455
ZN;32.12
Assess
7wnh.2.Amonomer0.62127-454
ZN;31.52
Assess
4iqr.2.Amonomer0.62126-456
ZN;30.00
Assess
7kw7.1.Fmonomer0.61225-456
30.93
Assess
4nqa.2.Bmonomer0.61124-456
ZN;27.11
Assess
4iqr.2.Bmonomer0.61126-456
ZN;30.00
Assess

51 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 27prw.1.Amonomer0.66101-433
ZN;30.93
Assess
Isoform 27prw.1.Bmonomer0.65102-433
ZN;30.93
Assess
Isoform 25uan.1.Amonomer0.64103-433
ZN;36.59
Assess
Isoform 24nqa.1.Amonomer0.6398-432
ZN;36.59
Assess
Isoform 25uan.1.Bmonomer0.63104-432
ZN;32.02
Assess
Isoform 27wnh.4.Amonomer0.63105-433
ZN;31.52
Assess
Isoform 24nqa.1.Bmonomer0.62101-432
ZN;27.11
Assess
Isoform 23dzy.1.Amonomer0.62102-431
ZN;36.59
Assess
Isoform 27wnh.2.Amonomer0.62104-431
ZN;31.52
Assess
Isoform 24iqr.2.Amonomer0.62103-433
ZN;30.00
Assess
Isoform 27kw7.1.Fmonomer0.61202-434
30.84
Assess
Isoform 24iqr.2.Bmonomer0.61103-433
ZN;30.00
Assess
Isoform 24nqa.2.Bmonomer0.60101-433
ZN;27.11
Assess
Isoform 37prw.1.Amonomer0.64102-440
ZN;30.54
Assess
Isoform 37prw.1.Bmonomer0.62102-440
ZN;30.54
Assess
Isoform 37wnh.4.Amonomer0.61105-440
ZN;31.83
Assess
Isoform 34nqa.1.Amonomer0.6198-439
ZN;35.87
Assess
Isoform 37kw7.1.Fmonomer0.61205-441
31.25
Assess
Isoform 35uan.1.Bmonomer0.60104-439
ZN;31.74
Assess
Isoform 35uan.1.Amonomer0.60103-440
ZN;35.87
Assess
Isoform 37wnh.2.Amonomer0.60104-438
ZN;31.83
Assess
Isoform 33dzy.1.Amonomer0.60102-438
ZN;35.87
Assess
Isoform 34iqr.2.Bmonomer0.60103-440
ZN;30.72
Assess
Isoform 34iqr.2.Amonomer0.60103-440
ZN;30.72
Assess
Isoform 34nqa.1.Bmonomer0.59101-439
ZN;27.14
Assess
Isoform 34nqa.2.Bmonomer0.59101-440
ZN;27.14
Assess
Isoform 47prw.1.Amonomer0.67101-395
ZN;28.47
Assess
Isoform 47prw.1.Bmonomer0.64102-395
ZN;28.47
Assess
Isoform 43dzu.1.Amonomer0.64102-392
32.43
Assess
Isoform 44nqa.1.Amonomer0.6499-393
32.66
Assess
Isoform 45uan.1.Amonomer0.64103-394
32.66
Assess
Isoform 47wnh.4.Amonomer0.63105-394
27.49
Assess
Isoform 44iqr.2.Amonomer0.63103-394
ZN;28.91
Assess
Isoform 44iqr.2.Bmonomer0.61103-394
ZN;28.91
Assess
Isoform 47wnh.2.Amonomer0.61104-392
ZN;27.49
Assess
Isoform 44nqa.2.Amonomer0.5997-394
35.62
Assess
Isoform 43dzy.1.Amonomer0.59102-392
35.62
Assess
Isoform 57prw.1.Amonomer0.65129-468
ZN;31.04
Assess
Isoform 57prw.1.Bmonomer0.63130-468
ZN;31.04
Assess
Isoform 57wnh.4.Amonomer0.61133-468
ZN;31.83
Assess
Isoform 55uan.1.Bmonomer0.61132-467
ZN;31.74
Assess
Isoform 54nqa.1.Amonomer0.61126-467
ZN;35.87
Assess
Isoform 57wnh.2.Amonomer0.61132-466
ZN;31.83
Assess
Isoform 54iqr.2.Amonomer0.61131-468
ZN;30.63
Assess
Isoform 55uan.1.Amonomer0.61131-468
ZN;35.87
Assess
Isoform 53dzy.1.Amonomer0.60130-466
ZN;35.87
Assess
Isoform 57kw7.1.Fmonomer0.60233-469
31.25
Assess
Isoform 54nqa.1.Bmonomer0.60128-467
ZN;27.06
Assess
Isoform 54iqr.2.Bmonomer0.60131-468
ZN;30.63
Assess
Isoform 54nqa.2.Bmonomer0.59128-468
ZN;27.06
Assess
Isoform 53dzu.1.Bmonomer0.57130-468
ZN;28.19
Assess